In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a MK-462;Maxalt;Maxalt Drug Master File in Korea (MK-462;Maxalt;Maxalt KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of MK-462;Maxalt;Maxalt. The MFDS reviews the MK-462;Maxalt;Maxalt KDMF as part of the drug registration process and uses the information provided in the MK-462;Maxalt;Maxalt KDMF to evaluate the safety and efficacy of the drug.
After submitting a MK-462;Maxalt;Maxalt KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their MK-462;Maxalt;Maxalt API can apply through the Korea Drug Master File (KDMF).
click here to find a list of MK-462;Maxalt;Maxalt suppliers with KDMF on PharmaCompass.